Contract 36F79724D0097
Ascensia Diabetes Care Us Inc · Department Of Veterans Affairs · August 27, 2025
Ascensia Diabetes Care Us Inc was awarded a federal contract by Department Of Veterans Affairs on August 27, 2025 for an undisclosed amount of work in in-vitro diagnostic substance manufacturing. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on November 25, 2025. If all options are exercised, the contract could reach $750,000.
Contract details
- PIID
- 36F79724D0097
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- First action
- August 27, 2025
- Latest action
- November 25, 2025
Description
65VII| SIN 42-2B | VOLUNTARY TEMPORARY PRICE REDUCTION (TPR) - CONFIDENTIAL PRICING FOR SPECIFIC GOVERNMENT AGENCIES
Modification timeline
-
November 25, 2025Mod P00004 · Supplemental Agreement For Work Within Scope$0
-
October 24, 2025Mod P00003 · Other Administrative Action65IB: ADMINISTRATIVE CHANGES - SIGNATORY AUTHORITY FORM UPDATE & SMALL BUSINESS SUBCONTRACTING PLAN ADMINISTRATOR POC CHANGE$0
-
August 27, 2025Mod P00002 · Supplemental Agreement For Work Within Scope65IB - SMALL BUSINESS SUBCONTRACTING PLAN - COMMERCIAL$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Veterans Affairs | April 1, 2026 | $735.4K |
| Bio Rad Laboratories Inc | Department Of Veterans Affairs | April 1, 2026 | $189.7K |
| Abbott Laboratories Inc. | Department Of Veterans Affairs | April 1, 2026 | $1.56M |
| Ortho-Clinical Diagnostics, Inc | Department Of Veterans Affairs | April 1, 2026 | $221.9K |
| Werfen USA Llc | Department Of Veterans Affairs | March 31, 2026 | $14.8K |
| Tosoh Bioscience, Inc. | Department Of Veterans Affairs | March 31, 2026 | $34.8K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79724D0097?
Contract 36F79724D0097 is a federal contract awarded to Ascensia Diabetes Care Us Inc by Department Of Veterans Affairs on August 27, 2025 for an undisclosed amount of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 36F79724D0097?
Ascensia Diabetes Care Us Inc won contract 36F79724D0097 from Department Of Veterans Affairs.
How much is contract 36F79724D0097 worth?
Contract 36F79724D0097 has obligated $0 to date but carries a potential ceiling of $750,000 if fully funded and all options are exercised.